Lir Life Sciences Corp. (CVE:SKNY) | Finanzwire

Basculer en Français

9724	Companies
194116	Keywords
125295	Articles
103293	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

BRIEF

published on 01/23/2026 at 00:05, 22 minutes ago

LIR Life Sciences Finalizes Study Design for Evaluating Transdermal Agents

Transdermal Delivery LIR Life Sciences Therapeutic Macromolecules Porcine Skin Model Needle-free Therapies
PRESS RELEASE

published on 01/23/2026 at 00:00, 27 minutes ago

LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
LIR Life Sciences Corp. announces study design for transdermal penetration of therapeutic macromolecules using ex vivo porcine skin. Focus on needle-free delivery strategies for larger therapeutics

Needle-free Delivery LIR Life Sciences Therapeutic Macromolecules Transdermal Penetration Ex Vivo Porcine Skin
BRIEF

published on 01/16/2026 at 00:05, 7 days ago

LIR Life Sciences Initiates Animal Study on Transdermal Obesity Therapies

Transdermal Delivery Obesity Therapy Animal Study LIR Life Sciences GLP/GIP-based
PRESS RELEASE

published on 01/16/2026 at 00:00, 7 days ago

LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies
LIR Life Sciences Corp. announces a controlled comparative animal study to evaluate needle-free transdermal delivery of GLP/GIP-based obesity therapies. Study aims to advance transdermal platform and simplify treatment for obesity

Lir Life Sciences Corp. Obesity Therapies GLP/GIP-based Controlled Study Needle-free Transdermal Delivery
BRIEF

published on 01/09/2026 at 00:05, 14 days ago

LIR Life Sciences Collaborates with Neuland Labs on Peptide Development

R&D Collaboration LIR Life Sciences Neuland Laboratories Cell Penetrating Peptides Transdermal Platform
PRESS RELEASE

published on 01/09/2026 at 00:00, 14 days ago

LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
LIR Life Sciences Corp. enters R&D Agreement with Neuland Labs for peptide formulations. Neuland Labs to provide services for preclinical evaluation and future collaboration

Lir Life Sciences Corp. Neuland Labs R&D Agreement Peptide Formulations Preclinical Evaluation
BRIEF

published on 12/19/2025 at 00:05, 1 month 4 days ago

LIR Life Sciences Appoints Dr. Peter Singer as Scientific Advisor

Obesity Treatment Health Innovation LIR Life Sciences Scientific Advisor Peter Singer
PRESS RELEASE

published on 12/19/2025 at 00:00, 1 month 4 days ago

LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
LIR Life Sciences Corp. announces Dr. Peter Singer, former WHO advisor, as Scientific Advisor. Focus on global obesity treatments & market making services

Market Making Services Lir Life Sciences Corp. Obesity Treatments Scientific Advisor Dr. Peter Singer
BRIEF

published on 12/12/2025 at 00:05, 1 month 11 days ago

LIR Life Sciences Pursues Needle-Free Obesity Therapy Delivery

Obesity Treatment Provisional Patent Needle-free Delivery GLP/GIP Therapies LIR Life Sciences
PRESS RELEASE

published on 12/12/2025 at 00:00, 1 month 11 days ago

LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
LIR Life Sciences files provisional patent for needle-free delivery platform for GLP/GIP therapies in obesity and metabolic diseases, aiming to improve treatment accessibility and adherence

Metabolic Diseases Obesity Provisional Patent GLP/GIP Therapies LIR Life Sciences

Accesswire

Published on 01/23/2026 at 00:00, 27 minutes ago

LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
Published on 01/22/2026 at 23:00, 1 hour 27 minutes ago

FutureGen Industries Announces Private Placement
Published on 01/22/2026 at 23:00, 1 hour 27 minutes ago

Green Bridge Metals Commences Diamond Drilling Program at the Titac Project, Minnesota, USA
Published on 01/22/2026 at 20:20, 4 hours 7 minutes ago

Tactical Resources Closes Financing
Published on 01/22/2026 at 19:35, 4 hours 52 minutes ago

Early Warning Report Filed Pursuant to National Instrument 62-103

View all ACCESSWIRE

EQS Group

Published on 01/22/2026 at 20:08, 4 hours 19 minutes ago

EQS-Adhoc: Discussions between Wacker Neuson SE and Doosan Bobcat Inc. regarding the acquisition of a majority stake and takeover of Wacker Neuson SE will not be continued
Published on 01/22/2026 at 19:08, 5 hours 19 minutes ago

EQS-Adhoc: BASF SE: BASF Group releases preliminary figures for full year 2025
Published on 01/22/2026 at 19:05, 5 hours 22 minutes ago

Verve Group Unifies Jun Group and Captify US Under Verve For Advertisers, Reinforcing its Strategy for Brands and Agencies
Published on 01/22/2026 at 19:00, 5 hours 27 minutes ago

HIAG expects profits to jump in 2025 financial year
Published on 01/22/2026 at 18:37, 5 hours 50 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 01/22/2026 at 18:00, 6 hours 27 minutes ago

TERACT - Independent expert appointment
Published on 01/22/2026 at 18:00, 6 hours 27 minutes ago

2025 revenue
Published on 01/22/2026 at 17:40, 6 hours 47 minutes ago

Disclosure of shares outstanding and voting rights - 22.01.2026
Published on 01/22/2026 at 08:45, 15 hours 42 minutes ago

Air Liquide voluntary low-carbon electricity sourcing gains momentum, with 3 TWh per year of additional PPAs started in 2025
Published on 01/22/2026 at 08:29, 15 hours 58 minutes ago

bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies

View all LES ECHOS COMFI WIRE